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Adipose tissue (AT), classically thought to be merely an energy store, has been shown to
produce inflammatory and metabolically active cytokines. Recently, adiponectin and lep-
tin, adipokines primarily synthesized by adipocytes, have attracted considerable attention
because inflammation has been suggested to modulate adipokine levels. However, the
regulation of adiponectin and leptin is complex and the knowledge about their synthesis
within the early onset of inflammation is poorly understood. The aim of this study was to
investigate if the synthesis of adiponectin and leptin is affected during the early phase of
an acute systemic inflammation. Eighteen healthy subjects were allocated to vaccination
against Salmonella typhi or to a control group, and adiponectin and leptin concentrations
measured in plasma during 24 h. Nine patients, without markers of inflammation, under-
going open heart surgery were investigated before and after the operation by analysis of
plasma levels and AT gene expression of adiponectin and leptin. Plasma interleukin (IL)-6
concentrations were measured in both cohorts. Plasma levels of IL-6 were doubled after
vaccination and increased 30-fold after open heart surgery. Plasma levels of adiponectin
and leptin were unchanged after vaccination whereas adiponectin and leptin tended to
decrease after surgery. The gene expression of adiponectin and leptin was unaltered in
omental and subcutaneous AT after surgery. Despite the use of two models of stimulated
in vivo systemic inflammation, we found no evidence of an early regulation of adiponectin
and leptin synthesis, indicating that these two adipokines are not key elements in an acute
systemic inflammation in humans.
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INTRODUCTION
Adipose tissue (AT), classically thought to be merely a storage place
for energy, has been shown to produce inflammatory and meta-
bolically active cytokines. Chronic activation of innate immune
responses within AT characterizes development of insulin resis-
tance and atherosclerosis (1). Recently, adiponectin and leptin,
two adipokines that primarily are synthesized by adipocytes, have
attracted considerable attention because inflammation has been
suggested to modulate adipokine levels. However, the regulation
of adiponectin and leptin is complex and the knowledge about
their synthesis within the early onset of inflammation is poorly
understood.
Acute inflammatory effects on AT are, in this context, of partic-
ular interest because of the role of adipokines in the development
of atherosclerosis.
Abbreviations: ACE, angiotensin converting enzyme inhibitor; ARB, angiotensin
receptor blocker; AT, adipose tissue; BMI, body mass index; cDNA, complementary
deoxyribonucleic acid; CPB, cardiopulmonary bypass; CV, coefficient of variation;
EDTA, ethylendiamid tetraacetic acid; ELISA, enzyme-linked immunosorbent assay;
IL, interleukin; LPS, lipopolysacharide; NA, non-applicable; NF-κB, nuclear fac-
tor κB; RIA, radioimmunoassay; RQ, relative quantification; RT-PCR, real-time
polymerase chain reaction; TNF, tumor necrosis factor.
Adiponectin decreases with increasing obesity and has been
described as anti-atherogenic including its positive effects on
insulin sensitivity, whereas leptin is involved in the central reg-
ulation of appetite (1–3). A rapid weight loss in obese individuals
decreases plasma levels of leptin while adiponectin do not change
(4). However, a longer period of weight loss and lifestyle changes
increases adiponectin plasma concentrations (5). Chronic kidney
disease is not only associated with an on-going chronic inflam-
mation in AT (6) but also associated with hyperadiponectinemia.
Unexpectedly,high, rather than low,concentrations of adiponectin
predict mortality. However, the role of adiponectin in a ure-
mic milieu is complex and the unfavorable effect might not be
explained only by a direct effect of adiponectin, but rather a conse-
quence of concurrent processes as wasting/malnutrition or volume
and salt overload, which may increase adiponectin levels (7).
Despite that plasma levels of leptin were increased and pos-
itively correlated with proinflammatory cytokines during sepsis
(8) and further associated with increased survival of sepsis (9),
few studies have addressed the influence of innate immunity on
adiponectin and leptin in humans.
Previously, two studies showed that leptin but not adiponectin
levels in plasma increase after open heart surgery (10) and
lipopolysaccharide (LPS) injection (11), respectively. After LPS
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treatment, only adiponectin RNA expression decreased in sub-
cutaneous AT. Another study showed no effect of inflammation,
caused by subarachnoidal hemorrhage, on adiponectin and leptin
RNA in subcutaneous AT (12).
The present study is a sub-study of two earlier studies where
acute inflammation was induced by vaccination (13) and open
heart surgery (14), respectively, with the objective to investigate
if innate immunity stimulates the synthesis of adiponectin and
leptin. Vaccination against Salmonella typhi, previously shown to
cause endothelial dysfunction and to activate coagulation (15–17),
is a safe model without any major side effects, which activates
the nuclear factor (NF)-κB regulatory pathway and results in
two- to fourfold increased plasma levels of IL-6 (13, 15). Open
heart surgery with cardiopulmonary by-pass (CPB) is one of the
strongest models of induced inflammation found in daily clinic.
It results in an extensive acute systemic inflammation with 30- to
40-fold increase in plasma levels of IL-6 after surgery (14, 18).
The activation of an acute phase response due to open heart
surgery and CPB is a complex process and possibly there are dif-
ferent triggers, as the surgical trauma itself and/or blood contact
with non-physiological surfaces of the CPB system (19). How-
ever, we have shown that the acute phase response, induced by
open heart surgery with CPB, stimulates AT to produce an innate
immune response due to up-regulation of the NF-κB regulatory
pathway (14).
The use of these two models of inflammation, both acting on
AT through activation of the NF-κB regulatory pathway (13, 14),
with a focus not only on plasma levels but also on mRNA in
both omental and subcutaneous AT will extend our knowledge
of adiponectin and leptin regulation. The objective of the present
study was to determine if adiponection and leptin are regulated by
the NF-κB regulatory pathway.
MATERIALS AND METHODS
SUBJECTS
Eighteen healthy volunteers (16 men and 2 post-menopausal
women) with a median age of 60 (49–67) years and BMI of 26.8
(19.8–38.8) were included in the vaccination study. Their basic
characteristics have been described in detail (13) and are in brief
presented in Table 1. Every second study subject was vaccinated
against Salmonella typhi (Typhim Vi, Sanofi Pasteur MSD, Swe-
den), whereas the remaining subjects served as controls. Subjects
arrived at 7 a.m. to the Karolinska University Hospital after fasting
overnight. After vaccination and/or first blood sample, partici-
pants had a light breakfast including a sandwich with cheese and
a cup of coffee or tea with sugar and milk as preferred.
Nine patients undergoing open heart surgery study were stud-
ied. They were eligible if they were planned for elective coronary
artery by-pass surgery and/or aortic or mitral valve replacement
according to a standard surgical procedure at the Department of
Thoracic Surgery at the Karolinska University Hospital, Solna,
Sweden. Patients were excluded if they had unstable coronary
artery disease or were treated with corticosteroids. All patients
were male with a median age of 65 (43–85) years and a BMI of 27.7
(21.1–32.4). All patients underwent AT biopsies and blood sam-
pling before and after cardiopulmonary bypass (CPB) as described
(14). Basic characteristics are presented in Table 1.
Table 1 | Basic characteristics.
Variable Vaccination study Open heart
surgery
study n=9
Vaccinated
n=9
Controls
n=9
Age, years 59 (56–66) 60 (49–67) 65 (43–85)
Sex (men/women) 8/9 (89%) 8/9 (89%) 9/0
Current smokers, N 2 (22%) 1 (11%) 1/9 (11%)
Former smokers, N 5 (56%) 4 (44%) 4/9 (44%)
Body weight, kg 93 (60–127) 90 (64–109) 79.9 (62.5–92.7)
BMI, kg/m2 25 (21–38.8) 28.2 (19.8–32.5) 27.7 (21.1–32.4)
CPB, min NA NA 98 (50–221)
Time between
sample 1 and 2, min
NA NA 125 (90–285)
History of Diabetes NA NA 1/9 (11%)
Current medication
Acetyl salicylic acid NA NA 7/9 (78%)
Beta blocker NA NA 2/9 (22%)
ACEi NA NA 2/9 (22%)
ARBs NA NA 2/9 (22%)
Calcium antagonists NA NA 3/9 (33%)
Diuretics NA NA 2/9 (22%)
Nitrates NA NA 4/9 (44%)
Statins NA NA 8/9 (89%)
Data presented as median (min and max values), numbers and percent.
No differences were found between vaccinated and controls in the vaccination
study.
ACEi, angiotensin converting enzyme inhibitor; ARBs, angiotensin receptor
blockers; BMI, body mass index, CPB, cardiopulmonary bypass, NA, data not
applicable.
All subjects provided written informed consent to participate
in the study and the study protocol was approved by the Ethics
Committee of Karolinska Institutet.
PLASMA ANALYSES
Blood sampling before and after vaccination and open heart
surgery, respectively, has been described in detail (13, 14). In brief,
in the vaccination study venous blood samples were obtained after
0, 4, 8, 12, and 24 h, without an indwelling venous catheter. In the
open heart surgery study, the first blood sampling was made after
approximately 30–40 min of surgery, before start of CPB. The sec-
ond blood sampling was made after the CPB had been turned
off with a median time of 125 (90–285) min between the paired
samples. The blood samples in the open heart surgery study were
obtained from an indwelling radial artery catheter. All blood sam-
ples were collected in vacutainer ethylendiamid tetraacetic acid
(EDTA) tubes and centrifuged in room temperature; where after
plasma was separated and stored at –80°C.
Plasma levels of adiponectin and leptin were analyzed in dupli-
cates using a double-antibody radioimmunoassay (RIA) (Linco,St.
Louis, MO, USA). Coefficient of variation (CV) for adiponectin
was 15.2% at low (2–4µg/mL) and 8.8% at high (26–54µg/mL)
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levels. CV for leptin was 4.7% at both low (2–4 ng/mL) and high
(10–15 ng/mL) levels.
Plasma levels of interleukin (IL-6) in the vaccination study were
determined in duplicates using a high sensitive ELISA (R&D Sys-
tems, Minneapolis, MN, USA) with an intra-assay CV of 9.5%.
Plasma levels of IL-6 in the open heart surgery study were analyzed
in duplicates using one Quantikine Human IL-6 Immunoassay
plate (R&D Systems) with an intra-assay CV of 10.2%.
ADIPOSE TISSUE BIOPSIES
Paired AT biopsies of approximately 1 cm3 were taken from nine
patients, whereof both omental and subcutaneous AT biopsies
from six patients, only omental AT biopsies from one patient and
only subcutaneous AT biopsies from two patients. The AT biopsies
were collected at the same time as the paired blood samples, before
institution of CPB and at 15–20 min after removal of the aor-
tic cross-clamp when the patient had been weaned off CPB. The
omental AT biopsies were taken through a small opening to the
abdomen in the bottom of the wound and the subcutaneous AT
biopsies were taken deeply from the side of the median sternotomy
incision.
GENE EXPRESSION STUDIES
The protocol for total RNA and cDNA preparation has been
described in detail (14). To investigate which housekeeping gene
to use, cDNA from omental AT from four subjects was ana-
lyzed using a TaqMan Human Endogenous Control Plate (Applied
Biosystems, Foster City, CA, USA). To analyze AT gene expres-
sion, cDNA was mixed with TaqMan® Universal PCR master Mix
(Applied Biosystems) according to the manufacturer’s instruc-
tions. RT-PCR was made using a custom made Low Density
Array (Applied Biosystems) with Adiponectin (Hs00605917_m1)
and Leptin (Hs00174877_m1) as target genes and cyclophilin A
(Hs99999904_m1) as an endogenous control gene, with a RT-PCR
protocol according to the manufacturer’s instructions. Relative
quantification of gene expression was calculated with cyclophilin
A as the house keeping gene using the first biopsy in every paired
analysis as a reference. Cyclophylin A demonstrated stability dur-
ing inflammation in the endogenous control plate experiment
described above with a similar cycle threshold value (Ct-value)
to the gene of interest.
STATISTICS
The present study had an 80% power (p< 0.05) to detect a dif-
ference of 7.4 and 5.6µg/mL in plasma levels of adiponectin
and leptin, respectively. Data are presented as median (min–
max), mean± SD or numbers (percent). Differences between
continuous variables have been analyzed using Mann–Whitney
U -test, Wilcoxon signed-rank test or mixed linear models. The
significance level was specified at p< 0.05.
RESULTS
Plasma IL-6 levels after vaccination and open heart surgery have
been reported (13, 14). Eight hours after vaccination, median
plasma levels of IL-6 were 2.0 (0.7–29.6) pg/mL compared to
1.2 (0.4–7.0) pg/ml in the control group (p= 0.02), while open
heart surgery resulted in an increase in plasma levels of IL-6 from
3.0 pg/mL (1.9–5.9) to 79.8 pg/mL (31.5–190.8) (p= 0.008).
Plasma levels of adiponectin and leptin were unaltered after
vaccination, showing similar levels as in the control group
(Figure 1). Plasma levels of adiponectin did not change (7.9± 4.6
vs. 6.2± 2.7µg/mL, p= 0.11) whereas leptin decreased from
8.8± 4.4 to 7.3± 4.1µg/mL (p= 0.04) after open heart surgery.
The relative RNA gene expression after open heart surgery,
expressed as change from baseline was analyzed in both omen-
tal and subcutaneous AT biopsies. Neither adiponectin nor leptin
RNA from omental AT did change after open heart surgery. Similar
results were obtained for subcutaneous AT (Figure 2).
DISCUSSION
The results of the present study showed that plasma levels of
adiponectin and leptin were unchanged after vaccination whereas
FIGURE 1 | Plasma levels of adiponectin and leptin before and after
vaccination. Box plots of plasma levels of adiponectin (A) and leptin (B) in
healthy subjects vaccinated against Salmonella typhi (n=9, black boxes) and
controls (n=9, open boxes). There was no difference between the two
groups using mixed linear models. Median, box: 25–75%, whiskers:
non-outlier range.
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FIGURE 2 | Relative adipose tissue RNA gene expression after open
heart surgery expressed as change from baseline. Relative quantification
(RQ) of adiponectin and leptin in (A) omental adipose tissue (AT) and
(B) subcutaneous AT. RQ levels expressed in relation to the house keeping
gene cyclophilin A, using the first biopsy in every paired analysis as a
reference (dotted line=no change). Omental AT (n=7) and subcutaneous AT
(n=8). There were no differences in gene expression of adiponectin or leptin
in neither omental, nor subcutaneous AT using Wilcoxon signed-rank test.
adiponectin and leptin tended to decrease after surgery. The gene
expression of adiponectin or leptin was unaltered in both omen-
tal and subcutaneous AT after surgery. Taking into account that
two validated methods of stimulated systemic inflammation were
used (15, 18) and that both plasma and gene expression of two
AT deposits were examined, it is highly unlikely that adiponectin
or leptin synthesis is affected during the early phase of an acute
systemic inflammatory response.
When circulating levels of adiponectin were investigated in
patients with acute myocardial infarction, a fairly mild stimulus to
inflammation, adiponectin was found to decrease after 24 h (20).
In our study, we did not find any differences in plasma levels of
adiponectin or leptin up to 24 h after vaccination. One possible
explanation is that vaccination, that resulted in increased gene
expression of tumor necrosis factor (TNF) in peripheral blood
mononuclear cells after 4 h and doubled plasma levels of IL-6
after 8 h (13), might have been too weak as a model of inflam-
mation. We have previously reported on a very rapid onset of a
strong innate immune response in AT following systemic inflam-
mation induced by open heart surgery, i.e., IL-6, IL-8/CXCL8,
and E-selectin showed a 100-fold increase in mRNA expression
in omental AT and in subcutaneous AT, these genes increased
even more, up to 200- to 400-fold (14). Therefore, we investi-
gated adiponectin and leptin in plasma and on a gene expression
level in AT before and after surgery. In plasma, adiponectin and
leptin tended to decrease, an effect that certainly is dependent on
plasma volume overload (21). In support for unchanged plasma
levels, we could not find any change in RNA of these adipokines
neither in omental nor in subcutaneous AT after surgery. The
results are in accordance with a previous study on open heart
surgery investigating epicardial and subcutaneous AT (10). The
present study extends these findings to omental AT. In contrast,
one recent study (22) showed that gene expression of adiponectin
decreased after surgery. However, in that study all patients had
preexistent inflammation due either to inflammatory bowel dis-
ease or malignancy making interpretation of the effects of acute
systemic inflammation difficult.
There are also some recent human studies that have focused
on both adiponectin and leptin synthesis in relation to acute
inflammation with other stimuli. Anderson and coworkers (11)
showed that leptin levels increased in plasma after LPS injection
but adiponectin levels remained unchanged. On a gene expression
level, only adiponectin was affected with suppressed expression in
subcutaneous AT, whereas there was only a trend toward increased
gene expression of leptin. The study by Jernås and coworkers
(12) showed no effect of inflammation, caused by subarachnoidal
hemorrhage, on adiponectin and leptin RNA gene expression in
subcutaneous AT. The reason for the discrepant results is not clear
but methodological issues have to be considered. The stimulus
to inflammation was different between the studies. Anderson and
coworkers used LPS whereas we (in the open heart surgery study)
and Jernås and coworkers used tissue damage to stimulate innate
immunity. All of these are strong stimuli but might activate dif-
ferent subsets of cells, including macrophages in AT. It can be
argued that the inflammatory stimulus on AT was similar in our
study compared with the study by Anderson and coworkers since
we had a similar strong gene expression of IL-6. Also the time-
frames were different with the possibility that we, in the open
heart surgery study, investigated gene expression in AT too early
(approximately 2 h) whereas Jernås and coworkers investigated
gene expression too late (days). Finally, there is a possibility that
the gene expression results in the study by Anderson and cowork-
ers might be false due to up-regulation of β-actin by inflammation
rather than down-regulation of adiponectin. In our study, we also
tested the results using other house-keeping genes than cyclophilin
All without changing the negative result (data not shown).
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To the best of our knowledge there are no in vitro studies on the
effects of LPS on human adipocytes regarding adiponectin. When
leptin synthesis has been studied in cultured human subcutaneous
adipocytes it has been demonstrated that TNF attenuated RNA
gene expression but in contrast, induced an increased release (23).
Furthermore, another in vitro experiment by Bruun and coworkers
have shown that the proinflammatory cytokines IL-1β and TNF
both decreased leptin gene expression and protein production but
interestingly IL-1β was found to elicit an early release of leptin
(24). The results of these two in vitro studies suggest a pre-formed
pool of leptin in human AT with a paracrine regulation to which
IL-1β and TNF could be important key regulators. However, this
pool has not yet been identified and it is not clear whether human
adipocytes stimulated in vitro adequately represent the situation
on a tissue level in vivo. In the present study, we could not find any
support for secretion of a preformed pool of leptin stimulated by
acute inflammation.
The main limitation of the present study is the low num-
ber of subjects investigated. In the plasma determination part
of the study, a mixed linear model was used to compensate for
the number of subjects investigated. Furthermore, in the gene
expression experiment, we used paired AT biopsies, from two
different AT sites (omental and subcutaneous), which minimize
the possible inter-individual variation. Another limitation is the
time-frame for AT biopsies with approximately 2 h between the
samples. An extended time between AT biopsy sampling might
have resulted in a positive result. An argument against this is
that inflammatory markers such as IL-6 increased more than
100-fold (14).
Both models of stimulated inflammation used in this study
activate inflammation through the NF-κB pathway and inter-
estingly, none of the models were shown to have any influence
on the synthesis of adiponectin or leptin, which indicates that
the NF-κB pathway is not involved in the regulation of these
two adipokines in an acute-phase response. This is also sup-
ported by a recent study by Diez and coworkers who showed
that leptin was not found to act as an inflammatory reactant
but more as a marker of nutritional status in patients with
pneumonia (25).
In conclusion, despite the use of two models of stimulated
in vivo systemic inflammation we found no evidence of an early
regulation of adiponectin and leptin synthesis, indicating that
these two adipokines are not key elements in the early phase of
an acute systemic inflammation in humans.
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